WESTBURY, N.Y.--(BUSINESS WIRE)--March 10, 2006--Vasomedical, Inc. (Nasdaq SC: VASO), a leader in the noninvasive treatment and management of cardiovascular diseases, reconfirmed that the majority of ...
Company Invites Congressmen to Local EECP Therapy Centers to Educate Them about How Non-Invasive Treatment Can Save the Healthcare System Millions Vasomedical, Inc. ("Vasomedical") (OTC BB: VASO), a ...
Westbury, NY - The relief from severe angina achieved by enhanced external counterpulsation (EECP®) is sustained for at least 2 years, according to a press release from Vasomedical Inc, the makers of ...
In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...
In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...
Vasomedical, Inc. (NASDAQSmallCap: VASO), announced today that five major third-party payers in the United Kingdom have expanded their reimbursement structures to include EECP external ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results